The Urinary Incontinence Treatment Network & Primary Outcomes of the SISTEr Trial
Michael E. Albo, M.D. |
| & Peggy Norton, MD |
| |
| Disclosure: |
- Michael E. Albo:
Allergan: Investigator
Astellas: Consultant or Advisor
Eli Lily: Investigator
Pfizer: Consultant or Advisor
-
Peggy Norton:
Nothing to disclose
|
| |
| The American Urological Association designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| |
| Estimated Time to Complete This Activity: 20 minutes |
|
 |
|
